Publication: 2491

Publication: 2491

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 23 (16) 3752-9

Year:: 2005
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:

Corr. Author:: Harvey B Niell
Authors:: Harvey B Niell James E Herndon Antonius A Miller Dorothy M Watson Alan B Sandler Karen Kelly Randolph S Marks Micheal C Perry Rafat H Ansari Grefory Otterson John Ellerton Everett E Vokes Mark R Green

Networks:

Study: Alliance-9732
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:

Keywords:: Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Small Cell, Cisplatin, Disease Progression, Etoposide, Female, Granulocyte Colony-Stimulating Factor, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Paclitaxel, Prospective Studies, Recombinant Proteins, Survival Rate, Time Factors